Literature DB >> 26360694

Lactic Acidosis during Entecavir Antiviral Treatment in a Patient with Hepatitis B Virus-related Decompensated Cirrhosis.

H Mao1, T Kang2.   

Abstract

Entities:  

Year:  2015        PMID： 26360694      PMCID： PMC4696625          DOI： 10.7727/wimj.2013.198

Source DB:  PubMed          Journal:  West Indian Med J        ISSN： 0043-3144            Impact factor:   0.171


× No keyword cloud information.
  5 in total

Review 1.  Entecavir in decompensated HBV cirrhosis: the future is looking brighter.

Authors:  Robert J Fontana
Journal:  J Hepatol       Date:  2009-12-16       Impact factor: 25.083

2.  Lactic acidosis during Entecavir treatment in decompensated hepatitis B virus-related cirrhosis.

Authors:  Alfredo Marzano; Andrea Marengo; Milena Marietti; Mario Rizzetto
Journal:  Dig Liver Dis       Date:  2011-07-22       Impact factor: 4.088

3.  Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study.

Authors:  Yun-Fan Liaw; Maria Raptopoulou-Gigi; Hugo Cheinquer; Shiv Kumar Sarin; Tawesak Tanwandee; Nancy Leung; Cheng-Yuan Peng; Robert P Myers; Robert S Brown; Lennox Jeffers; Naoky Tsai; Jolanta Bialkowska; Shijie Tang; Suzanne Beebe; Elizabeth Cooney
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

4.  Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis.

Authors:  Jong Jin Hyun; Yeon Seok Seo; Eileen Yoon; Tae Hyung Kim; Dong Jin Kim; Hyun Seok Kang; Eun Suk Jung; Jeong Han Kim; Hyonggin An; Ji Hoon Kim; Hyung Joon Yim; Jong Eun Yeon; Hong Sik Lee; Kwan Soo Byun; Soon Ho Um; Chang Duck Kim; Ho Sang Ryu
Journal:  Liver Int       Date:  2011-11-17       Impact factor: 5.828

5.  Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function.

Authors:  Christian M Lange; Jörg Bojunga; Wolf Peter Hofmann; Katrin Wunder; Ulrike Mihm; Stefan Zeuzem; Christoph Sarrazin
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425
  5 in total
  1 in total

Review 1.  Adverse effects of oral antiviral therapy in chronic hepatitis B.

Authors:  Bircan Kayaaslan; Rahmet Guner
Journal:  World J Hepatol       Date:  2017-02-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.